A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia

Oxytocin increases trust in humans

Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690 · see citing works

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484 · see citing works

The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

Jentsch, J., & Roth, R. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,349 · see citing works

Sensorimotor Gating and Schizophrenia

Braff, D. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810140081011 · Cited by 1,312 · see citing works

The NIMH-MATRICS Consensus Statement on Negative Symptoms

Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj053 · Cited by 1,311 · see citing works

Oxytocin shapes the neural circuitry of trust and trust adaptation in humans

Baumgartner, T., Heinrichs, M., Vonlanthen, A., Fischbacher, U., & Fehr, E. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.009 · Cited by 1,258 · see citing works

Social amnesia in mice lacking the oxytocin gene

Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130 · see citing works

Oxytocin in the Medial Amygdala is Essential for Social Recognition in the Mouse

Ferguson, J. N., Aldag, J. M., Insel, T. R., & Young, L. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08278.2001 · Cited by 1,043 · see citing works

Dendritic peptide release and peptide-dependent behaviours

Ludwig, M., & Leng, G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1845 · Cited by 945 · see citing works

Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice

Takayanagi, Y., Yoshida, M., Bielsky, I. F., Ross, H. E., Kawamata, M., Onaka, T., Yanagisawa, T., Kimura, T., Matzuk, M. M., Young, L. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505312102 · Cited by 806 · see citing works

Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala

Huber, D., Veinante, P., & Stoop, R. (2005) · Science · doi:10.1126/science.1105636 · Cited by 804 · see citing works

Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles

Liu, Y., & Wang, Z. X. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00555-4 · Cited by 580 · see citing works

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 576 · see citing works

Realistic expectations of prepulse inhibition in translational models for schizophrenia research

Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., & Braff, D. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1072-4 · Cited by 529 · see citing works

Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice

Neumann, I. D., Maloumby, R., Beiderbeck, D. I., Lukas, M., & Landgraf, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.003 · Cited by 511 · see citing works

Neuromodulation by Oxytocin and Vasopressin

Stoop, R. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.025 · Cited by 506 · see citing works

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

Weinberger, D. R., & Lipska, B. K. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)00013-c · Cited by 468 · see citing works

Modulating social behavior with oxytocin: How does it work? What does it mean?

Churchland, P. S., & Winkielman, P. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.003 · Cited by 464 · see citing works

Oxytocin, vasopressin, and social recognition in mammals

Bielsky, I. F., & Young, L. J. (2004) · Peptides · doi:10.1016/j.peptides.2004.05.019 · Cited by 460 · see citing works

Deconstructing negative symptoms of schizophrenia: Avolition–apathy and diminished expression clusters predict clinical presentation and functional outcome

Strauss, G. P., Horan, W. P., Kirkpatrick, B. W., Fischer, B. A., Keller, W. R., Miski, P., Buchanan, R. W., Green, M. F., & Carpenter, W. T. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.01.015 · Cited by 424 · see citing works

Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics

Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., & Guillon, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02303.x · Cited by 423 · see citing works

Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia

Marder, S. R., & Fenton, W. S. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.010 · Cited by 419 · see citing works

The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice

Lukas, M., Toth, I., Reber, S. O., Slattery, D. A., Veenema, A. H., & Neumann, I. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.95 · Cited by 403 · see citing works

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?

Kantrowitz, J. T., & Javitt, D. C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.006 · Cited by 397 · see citing works

Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders

Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390 · cited 1× · see citing works

Oxytocin Selectively Gates Fear Responses Through Distinct Outputs from the Central Amygdala

Viviani, D., Charlet, A., van den Burg, E., Robinet, C., Hurni, N., Abatis, M., Magara, F., & Stoop, R. (2011) · Science · doi:10.1126/science.1201043 · Cited by 381 · see citing works

Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study

Loup, F., Tribollet, E., Dubois-Dauphin, M., & Dreifuss, J. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90345-v · Cited by 378 · see citing works

Exogenous and evoked oxytocin restores social behavior in the <i>Cntnap2</i> mouse model of autism

Peñagarikano, O., Lázaro, M. T., Lu, X.-H., Gordon, A., Dong, H., Lam, H. A., Peles, E., Maidment, N. T., Murphy, N. P., Yang, X. W., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010257 · Cited by 378 · see citing works

Dopamine and Oxytocin Interactions Underlying Behaviors: Potential Contributions to Behavioral Disorders

Baskerville, T. A., & Douglas, A. J. (2010) · CNS Neuroscience &amp; Therapeutics · doi:10.1111/j.1755-5949.2010.00154.x · Cited by 377 · see citing works

Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism

Sala, M., Braida, D., Lentini, D., Busnelli, M., Bulgheroni, E., Capurro, V., Finardi, A., Donzelli, A., Pattini, L., Rubino, T., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.022 · Cited by 375 · see citing works

Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade

Tomizawa, K., Iga, N., Lü, Y.-F., Moriwaki, A., Matsushita, M., Li, S., Miyamoto, O., Itano, T., & Matsui, H. (2003) · Nature Neuroscience · doi:10.1038/nn1023 · Cited by 372 · see citing works

Oxytocin–dopamine interactions mediate variations in maternal behavior in the rat

Shahrokh, D. K., Zhang, T.-Y., Diorio, J., Gratton, A., & Meaney, M. J. (2010) · Endocrinology · doi:10.1210/en.2009-1271 · Cited by 366 · see citing works

Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment

Millan, M. J., Fone, K. C. F., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 354 · see citing works

Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse

Winslow, J. T., Hearn, E. F., Ferguson, J., Young, L. J., Matzuk, M. M., & Insel, T. R. (2000) · Hormones and Behavior · doi:10.1006/hbeh.1999.1566 · Cited by 348 · see citing works

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients

Feifel, D., Macdonald, K., Nguyen, A., Cobb, P., Warlan, H., Galangue, B., Minassian, A., Becker, O., Cooper, J., Perry, W., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.039 · Cited by 308 · see citing works

Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia

Pedersen, C. A., Gibson, C. M., Rau, S. W., Salimi, K., Smedley, K. L., Casey, R. L., Leserman, J., Jarskog, L. F., & Penn, D. L. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.027 · Cited by 305 · see citing works

Oxytocin, brain physiology, and functional connectivity: A review of intranasal oxytocin fMRI studies

Bethlehem, R. A. I., van Honk, J., Auyeung, B., & Baron-Cohen, S. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.10.011 · Cited by 285 · see citing works

Immunohistochemical localization of oxytocin receptors in human brain

Boccia, M. L., Petrusz, P., Suzuki, K., Marson, L., & Pedersen, C. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.048 · Cited by 276 · see citing works

A conditional knockout mouse line of the oxytocin receptor

Lee, H.-J., Caldwell, H. K., Macbeth, A. H., Tolu, S. G., & Young, W. S. (2008) · Endocrinology · doi:10.1210/en.2007-1710 · Cited by 269 · see citing works

Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles

Bales, K. L., Perkeybile, A. M., Conley, O. G., Lee, M. H., Guoynes, C. D., Downing, G. M., Yun, C. R., Solomon, M., Jacob, S., & Mendoza, S. P. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.025 · Cited by 265 · see citing works

Inhaled oxytocin amplifies both vicarious reinforcement and self reinforcement in rhesus macaques ( <i>Macaca mulatta</i> )

Chang, S. W. C., Barter, J. W., Ebitz, R. B., Watson, K. K., & Platt, M. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114621109 · Cited by 252 · cited 3× · see citing works

Where in the brain is morality? Everywhere and maybe nowhere

Young, L., & Dungan, J. A. (2011) · Social Neuroscience · doi:10.1080/17470919.2011.569146 · Cited by 239 · see citing works

Social approach behaviors in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments

Crawley, J. N., Chen, T., Puri, A., Washburn, R., Sullivan, T. L., Hill, J. M., Young, N. B., Nadler, J. J., Moy, S. S., Young, L. J., et al. (2007) · Neuropeptides · doi:10.1016/j.npep.2007.02.002 · Cited by 232 · see citing works

Dopaminergic basis of salience dysregulation in psychosis

Winton-Brown, T. T., Fusar-Poli, P., Ungless, M. A., & Howes, O. D. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.11.003 · Cited by 231 · see citing works

Epigenetic modification of the oxytocin receptor gene influences the perception of anger and fear in the human brain

Puglia, M. H., Lillard, T. S., Morris, J. P., & Connelly, J. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422096112 · Cited by 216 · see citing works

The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities

Carpenter, W. T., & Koenig, J. I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301639 · Cited by 210 · see citing works

Social Interaction Deficits Caused by Chronic Phencyclidine Administration are Reversed by Oxytocin

Lee, P. R., Brady, D. L., Shapiro, R. A., Dorsa, D. M., & Koenig, J. I. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300722 · Cited by 199 · see citing works

Chronic and acute intranasal oxytocin produce divergent social effects in mice

Huang, H., Michetti, C., Busnelli, M., Managò, F., Sannino, S., Scheggia, D., Giancardo, L., Sona, D., Murino, V., Chini, B., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.310 · Cited by 199 · see citing works

Animal models for the negative symptoms of schizophrenia

Ellenbroek, B. A., & Cools, A. R. (2000) · Behavioural Pharmacology · doi:10.1097/00008877-200006000-00006 · Cited by 198 · see citing works

An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism

Méziane, H., Schaller, F., Bauer, Š., Villard, C., Matarazzo, V. A., Riet, F., Guillon, G., Lafitte, D., Desarménien, M. G., Tauber, M., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.010 · Cited by 194 · see citing works

Oxytocin-Induced Analgesia and Scratching Are Mediated by the Vasopressin-1A Receptor in the Mouse

Schorscher-Petcu, A., Sotocinal, S., Ciura, S., Dupre, A., Ritchie, J., Sorge, R. E., Crawley, J. N., Hu, S.-B., Nishimori, K., Young, L. J., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1594-10.2010 · Cited by 189 · see citing works

The neuroanatomical distribution of oxytocin receptor binding and mRNA in the male rhesus macaque (Macaca mulatta)

Freeman, S. M., Inoue, K., Smith, A. L., Goodman, M. M., & Young, L. J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.023 · Cited by 185 · see citing works

Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders

MacDonald, K., & Feifel, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00035 · Cited by 181 · see citing works

Neuroendocrine basis of social recognition

Winslow, J. T., & Insel, T. R. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.03.009 · Cited by 180 · see citing works

Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies

Wigton, R., Radua, J., Allen, P., Averbeck, B., Meyer-Lindenberg, A., McGuire, P., Shergill, S. S., & Fusar-Poli, P. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130289 · Cited by 179 · see citing works

Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia.

Rosenfeld, A. J., Lieberman, J. A., & Jarskog, L. F. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq015 · Cited by 178 · see citing works

Human neuroimaging of oxytocin and vasopressin in social cognition

Zink, C. F., & Meyer-Lindenberg, A. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.01.016 · Cited by 176 · see citing works

Animal models for the study of human disease

Conn, P. (2013) · Elsevier eBooks · doi:10.1016/c2011-0-05225-0 · Cited by 169 · see citing works

Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy

Hirota, T., Schwartz, S., & Correll, C. U. (2014) · Journal of the American Academy of Child &amp; Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.009 · Cited by 161 · see citing works

RNAi knockdown of oxytocin receptor in the nucleus accumbens inhibits social attachment and parental care in monogamous female prairie voles

Keebaugh, A. C., Barrett, C. E., Laprairie, J. L., Jenkins, J. J., & Young, L. J. (2015) · Social Neuroscience · doi:10.1080/17470919.2015.1040893 · Cited by 150 · see citing works

Oxytocin-Augmented Social Cognitive Skills Training in Schizophrenia

Davis, M. C., Green, M. F., Lee, J., Horan, W. P., Senturk, D., Clarke, A. D., & Marder, S. R. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.68 · Cited by 149 · see citing works

Emotion recognition and oxytocin in patients with schizophrenia

Averbeck, B. B., Bobin, T., Evans, S., & Shergill, S. S. (2011) · Psychological Medicine · doi:10.1017/s0033291711001413 · Cited by 144 · see citing works

Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats

Bowen, M. T., Carson, D. S., Spiro, A., Arnold, J. C., & McGregor, I. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027237 · Cited by 143 · see citing works

Cognitive function in schizophrenia

Weinberger, D. R., & Gallhofer, B. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199709004-00006 · Cited by 139 · see citing works

Peripheral Pulses of Oxytocin Increase Partner Preferences in Female, but Not Male, Prairie Voles

Cushing, B. S., & Carter, C. S. (2000) · Hormones and Behavior · doi:10.1006/hbeh.1999.1558 · Cited by 136 · see citing works

Long-term exposure to intranasal oxytocin in a mouse autism model

Bales, K. L., Solomon, M., Jacob, S., Crawley, J. N., Silverman, J. L., Larke, R. H., Sahagún, E., Puhger, K. R., Pride, M. C., & Mendoza, S. P. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.117 · Cited by 131 · see citing works

Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice

Qi, J., Yang, J.-Y., Song, M., Li, Y., Wang, F., & Wu, C.-F. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0245-8 · Cited by 129 · see citing works

Oxytocin-messages via the cerebrospinal fluid: Behavioral effects; a review

Veening, J. G., A, T. R. D. J., & Barendregt, H. P. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.05.004 · Cited by 126 · see citing works

Effects of single dose intranasal oxytocin on social cognition in schizophrenia

Davis, M. C., Lee, J., Horan, W. P., Clarke, A. D., McGee, M. R., Green, M. F., & Marder, S. R. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.023 · Cited by 124 · see citing works

Intranasal oxytocin selectively attenuates rhesus monkeys’ attention to negative facial expressions

Parr, L. A., Modi, M., Siebert, E., & Young, L. J. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.02.011 · Cited by 124 · see citing works

Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

Hoffman, D. (1992) · Journal of Neural Transmission · doi:10.1007/bf01245347 · Cited by 122 · see citing works

Genome-Wide Linkage Analyses of 12 Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia

Greenwood, T. A., Swerdlow, N. R., Gur, R. E., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Green, M. F., Gur, R. C., Lazzeroni, L. C., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020186 · Cited by 122 · see citing works

Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating

Feifel, D., & Reza, T. L. (1999) · Psychopharmacology · doi:10.1007/s002130050811 · Cited by 121 · see citing works

A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics

Kumari, V., Antonova, E., Geyer, M. A., Ffytche, D. H., Williams, S., & Sharma, T. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007139 · Cited by 121 · see citing works

A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis

Cacciotti-Saija, C., Langdon, R., Ward, P. B., Hickie, I. B., Scott, E. M., Naismith, S. L., Moore, L., Alvares, G. A., Redoblado Hodge, M. A., & Guastella, A. J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu094 · Cited by 119 · see citing works

Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia

Feifel, D., MacDonald, K. S., Cobb, P., & Minassian, A. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.05.018 · Cited by 117 · see citing works

Towards improved animal models for evaluating social cognition and its disruption in schizophrenia: The CNTRICS initiative

Millan, M. J., & Bales, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.09.012 · Cited by 116 · see citing works

Oxytocin administration enhances controlled social cognition in patients with schizophrenia

Woolley, J. D., Chuang, B., Lam, O., Lai, W., O’Donovan, A., Rankin, K. P., Mathalon, D. H., & Vinogradov, S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.024 · Cited by 116 · see citing works

Oxytocin but not vasopressin facilities social recognition following injection into the medial preoptic area of the rat brain

Popik, P., & van Ree, J. M. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90010-r · Cited by 114 · see citing works

The Hippocampus and Nucleus Accumbens as Potential Therapeutic Targets for Neurosurgical Intervention in Schizophrenia

Mikell, C. B., McKhann, G. M., Segal, S., McGovern, R. A., Wallenstein, M. B., & Moore, H. M. (2009) · Stereotactic and Functional Neurosurgery · doi:10.1159/000225979 · Cited by 113 · see citing works

Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia

Goldman, M. B., Gomes, A. M., Carter, C. S., & Lee, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2193-8 · Cited by 112 · see citing works

Oxytocin in schizophrenia: a review of evidence for its therapeutic effects

MacDonald, K. S., & Feifel, D. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00634.x · Cited by 111 · see citing works

Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors

Song, Z., McCann, K. E., McNeill, J. K., Larkin, T. E., Huhman, K. L., & Albers, H. E. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.08.005 · Cited by 111 · see citing works

Prenatal stress induces body weight deficit and behavioural alterations in rats: the effect of diazepam

Drago, F., Leo, F., & Giardina, L. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00032-7 · Cited by 111 · see citing works

Developing treatments for cognitive deficits in schizophrenia: The challenge of translation

Young, J. W., & Geyer, M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114555252 · Cited by 110 · see citing works

Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice

Caldwell, H. K., Stephens, S. L., & Young, W. S. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002150 · Cited by 108 · see citing works

Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia

Modabbernia, A., Rezaei, F., Salehi, B., Jafarinia, M., Ashrafi, M., Tabrizi, M. H., Hosseini, S. M. R., Tajdini, M., Ghaleiha, A., & Akhondzadeh, S. (2012) · CNS Drugs · doi:10.1007/s40263-012-0022-1 · Cited by 107 · see citing works

Oxytocin in learning and addiction: From early discoveries to the present

Sarnyai, Z., & Kovács, G. L. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.019 · Cited by 106 · see citing works

The role of oxytocin-dopamine interactions in cocaine-induced locomotor hyperactivity

Kovàcs, G. L., Sarnyai, Z., Babarczi, E., Szabó, G., & Telegdy, G. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90095-9 · Cited by 101 · see citing works

Dopamine modulates synaptic plasticity in dendrites of rat and human dentate granule cells

Hamilton, T. J., Wheatley, B. M., Sinclair, D. B., Bachmann, M., Larkum, M. E., & Colmers, W. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011558107 · Cited by 99 · see citing works

Prosocial effects of oxytocin in two mouse models of autism spectrum disorders

Teng, B. L., Nonneman, R. J., Agster, K. L., Nikolova, V. D., Davis, T. T., Riddick, N. V., Baker, L. K., Pedersen, C. A., Jarstfer, M. B., & Moy, S. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.038 · Cited by 98 · see citing works

Intranasal oxytocin effects on social cognition: A critique

Evans, S. L., Dal Monte, O., Noble, P., & Averbeck, B. B. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.008 · Cited by 97 · see citing works

Repeated intranasal oxytocin administration in early life dysregulates the HPA axis and alters social behavior

Rault, J.-L., Carter, C. S., Garner, J. P., Marchant, J. N., Richert, B. T., & Lay, D. C. (2013) · Physiology &amp; Behavior · doi:10.1016/j.physbeh.2013.02.007 · Cited by 94 · see citing works

Acute and repeated intranasal oxytocin administration exerts anti-aggressive and pro-affiliative effects in male rats

Calcagnoli, F., Kreutzmann, J. C., de Boer, S. F., Althaus, M., & Koolhaas, J. M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.019 · Cited by 92 · see citing works

A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia

Gibson, C. M., Penn, D. L., Smedley, K. L., Leserman, J., Elliott, T., & Pedersen, C. A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.009 · Cited by 88 · see citing works

Improving social perception in schizophrenia: The role of oxytocin

Fischer-Shofty, M., Brüne, M., Ebert, A., Shefet, D., Levkovitz, Y., & Shamay‐Tsoory, S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.006 · Cited by 83 · see citing works

Action of Modafinil—Increased Motivation Via the Dopamine Transporter Inhibition and D1 Receptors?

Young, J. W., & Geyer, M. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.015 · Cited by 82 · see citing works

Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction

DUNCAN, G., MOY, S., LIEBERMAN, J., & KOLLER, B. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.09.017 · Cited by 82 · see citing works

Neuroimaging studies of social cognition in schizophrenia

Fujiwara, H., Yassin, W., & Murai, T. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12258 · Cited by 81 · see citing works

On the role of volume transmission and receptor-receptor interactions in social behaviour: focus on central catecholamine and oxytocin neurons

Fuxe, K., Borroto-Escuela, D. O., Romero-Fernandez, W., Ciruela, F., Manger, P., Leo, G., Díaz-Cabiale, Z., & Agnati, L. F. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.062 · Cited by 81 · see citing works

Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: Results from a randomized double blind placebo controlled pilot study

Lee, M. R., Wehring, H. J., McMahon, R. P., Linthicum, J., Cascella, N., Liu, F., Bellack, A., Buchanan, R. W., Strauss, G. P., Contoreggi, C., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.001 · Cited by 80 · see citing works

Oxytocin attenuates neural reactivity to masked threat cues from the eyes

Kanat, M., Heinrichs, M., Schwarzwald, R., & Domes, G. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.183 · Cited by 77 · see citing works

Intracerebroventricular oxytocin administration in rats enhances object recognition and increases expression of neurotrophins, microtubule‐associated protein 2, and synapsin I

Havránek, T., Zatkova, M., Lestanova, Z., Bačová, Z., Mravec, B., Hodosy, J., Štrbák, V., & Bakoš, J. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23559 · Cited by 71 · see citing works

Oxytocin and social cognition in rhesus macaques: Implications for understanding and treating human psychopathology

Chang, S. W. C., & Platt, M. L. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.006 · Cited by 71 · see citing works

Effects of Oxytocin on Neural Response to Facial Expressions in Patients with Schizophrenia

Shin, N. Y., Park, H. Y., Jung, W. H., Park, J. W., Yun, J., Jang, J. H., Kim, S. N., Han, H. J., Kim, S.-Y., Kang, D., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.41 · Cited by 69 · see citing works

Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats

Uvnäs‐Moberg, K., Alster, P., & Svensson, T. H. (1992) · Psychopharmacology · doi:10.1007/bf02247726 · Cited by 68 · see citing works

Oxytocin modulates amygdala reactivity to masked fearful eyes

Kanat, M., Heinrichs, M., Mader, I., van Elst, L. T., & Domes, G. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.111 · Cited by 65 · see citing works

Stimulant-induced psychosis: an evaluation of animal methods.

Segal, D. S., Geyer, M. A., & Schuckit, M. A. (1981) · PubMed · Cited by 63 · see citing works

CNTRICS Final Task Selection: Long-Term Memory

Ragland, J. D., Cools, R., Frank, M. J., Pizzagalli, D. A., Preston, A. R., Ranganath, C., & Wagner, A. D. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn134 · Cited by 57 · see citing works

Chronic enhancement of brain oxytocin levels causes enduring anti-aggressive and pro-social explorative behavioral effects in male rats

Calcagnoli, F., Meyer, N., de Boer, S. F., Althaus, M., & Koolhaas, J. M. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.03.008 · Cited by 49 · see citing works

Hormones in the treatment of psychoses.

Bujanow, W. (1972) · BMJ · doi:10.1136/bmj.4.5835.298-c · Cited by 47 · see citing works

Dopamine neurotransmission in the nucleus accumbens may be involved in oxytocin-enhanced grooming behavior of the rat

Drago, F., Caldwell, J. D., Pedersen, C. A., Continella, G., Scapagnini, U., & Prange, A. J. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90168-1 · Cited by 45 · see citing works

Is Oxytocin an Anti-Schizophrenic Hormone?

Bujanow, W. (1974) · Canadian Psychiatric Association Journal · doi:10.1177/070674377401900323 · Cited by 45 · see citing works

Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry

Kiss, A., Bundzikova, J., Pirník, Z., & Mikkelsen, J. D. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22226 · Cited by 43 · see citing works

The effects of a single dose of oxytocin on working memory in schizophrenia

Michalopoulou, P. G., Averbeck, B. B., Kalpakidou, A. K., Evans, S., Bobin, T., Kapur, S., & Shergill, S. S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.029 · Cited by 41 · see citing works

Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol

Schiller, D., ZUCKERMAN, L., & Weiner, I. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.03.002 · Cited by 40 · see citing works

Oxytocin enhances the inhibitory effects of diazepam in the rat central medial amygdala

Viviani, D., Terrettaz, T., Magara, F., & Stoop, R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.039 · Cited by 40 · see citing works

Add‐on or step‐up trials for new drug development in rheumatoid arthritis: A new standard?

Boers, M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11141 · Cited by 38 · see citing works

Oxytocin attenuates the cocaine-induced exploratory hyperactivity in mice

Sarnyai, Z., Szabó, G., Kovács, G. L., & Telegdy, G. (1990) · NeuroReport · doi:10.1097/00001756-199011000-00006 · Cited by 37 · see citing works

The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating

Feifel, D., Shilling, P. D., & Belcher, A. M. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.004 · Cited by 37 · see citing works

Roles of oxytocin in spatial learning and memory in the nucleus basalis of Meynert in rats

Wu, W., & Yu, L. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.02.017 · Cited by 32 · see citing works

Modeling combined schizophrenia-related behavioral and metabolic phenotypes in rodents

Sarnyai, Z., Jashar, C., & Olivier, B. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.016 · Cited by 22 · see citing works

Effects of oxytocin, des-glycinamide-oxytocin and anti-oxytocin serum on the α-MPT-induced disappearance of catecholamines in the rat brain

Kovács, G. L., & Telegdy, G. (1983) · Brain Research · doi:10.1016/0006-8993(83)90497-3 · Cited by 20 · see citing works

Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats.

Feifel, D., Shilling, P. D., & Melendez, G. (2011) · Behavioral Neuroscience · doi:10.1037/a0022691 · Cited by 19 · see citing works

Peripherally administered oxytocin modulates latent inhibition in a manner consistent with antipsychotic drugs

Feifel, D., Shilling, P. D., Hillman, J., Maisel, M., Winfield, J., & Melendez, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.10.023 · Cited by 13 · see citing works

Dose-dependent and time-dependent action of oxytocin on chick memory

Davis, J. L., Pico, R. M., & Cherkin, A. (1983) · Brain Research · doi:10.1016/0006-8993(83)90669-8 · Cited by 11 · see citing works

[Psychotropic properties of oxytocin].

Vd, B., Sm, T., & Tk, L. (1984) · PubMed · Cited by 11 · see citing works

Erratum: Effects of Oxytocin on Neural Response to Facial Expressions in Patients with Schizophrenia

Shin, N. Y., Park, H. Y., Jung, W. H., Park, J. W., Yun, J., Jang, J. H., Kim, S. N., Han, H. J., Kim, S.-Y., Kang, D., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.78 · Cited by 11 · see citing works

Modeling Schizophrenia in Animals

Feifel, D., & Shilling, P. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00030-0 · Cited by 7 · see citing works

Limits of add-on trials: antirheumatic drugs

Ottolenghi, L., Bertelè, V., & Garattini, S. K. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0545-z · Cited by 5 · see citing works

The Use of Placebo-Controlled Clinical Trials for the Approval of Psychiatric Drugs: Part II-Ethical Considerations Related to the Individual Participant.

Feifel, D. (2009) · PubMed · Cited by 2 · see citing works

Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research

Quintana, D. S., Lischke, A., Grace, S., Scheele, D., Ma, Y., & Becker, B. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00864-7 · Cited by 263 · see citing works

Comparative Perspectives on Oxytocin and Vasopressin Receptor Research in Rodents and Primates: Translational Implications

Freeman, S. M., & Young, L. J. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12382 · Cited by 196 · see citing works

Brain oxytocin: how puzzle stones from animal studies translate into psychiatry

Grinevich, V., & Neumann, I. D. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0802-9 · Cited by 189 · see citing works

Treatment of negative symptoms: Where do we stand, and where do we go?

Aleman, A., Lincoln, T. M., Bruggeman, R., Melle, I. S., Arends, J., Arango, C., & Knegtering, H. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.05.015 · Cited by 177 · see citing works

Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice

Yamamoto, Y., Liang, M., Munesue, S., Deguchi, K., Harashima, A., Furuhara, K., Yuhi, T., Zhong, J., Akther, S., Goto, H., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0325-6 · Cited by 171 · see citing works

Treating Negative Symptoms in Schizophrenia: an Update

Remington, G. J., Foussias, G., Fervaha, G., Agid, O., Takeuchi, H., Lee, J., & Hahn, M. (2016) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-016-0075-8 · Cited by 167 · see citing works

Molecular Basis of Oxytocin Receptor Signalling in the Brain: What We Know and What We Need to Know

Busnelli, M., & Chini, B. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_6 · Cited by 161 · see citing works

Attachment, Neurobiology, and Mentalizing along the Psychosis Continuum

Debbané, M., Salaminios, G., Luyten, P., Badoud, D., Armando, M., Solida-Tozzi, A., Fonagy, P., & Brent, B. K. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00406 · Cited by 163 · see citing works

Oxytocin and social functioning

Jones, C., Barrera, I., Brothers, S., Ring, R., & Wahlestedt, C. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/cjones · Cited by 132 · see citing works

Overview of human oxytocin research

Kendrick, K. M., Guastella, A. J., & Becker, B. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_19 · Cited by 121 · see citing works

Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward

Bradley, E., & Woolley, J. D. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.007 · Cited by 88 · see citing works

Naringin and Naringenin Polyphenols in Neurological Diseases: Understandings from a Therapeutic Viewpoint

Emran, T. B., Islam, F., Nath, N., Sutradhar, H., Das, R. C., Mitra, S., Alshahrani, M. M., Alhasaniah, A. H., & Sharma, R. (2022) · Life · doi:10.3390/life13010099 · Cited by 86 · see citing works

Potential of Oxytocin in the Treatment of Schizophrenia

Shilling, P. D., & Feifel, D. (2016) · CNS Drugs · doi:10.1007/s40263-016-0315-x · Cited by 82 · see citing works

Oxytocin and behavior: lessons from knockout mice

Caldwell, H. K., Aulino, E. A., Freeman, A. R., Miller, T. V., & Witchey, S. K. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22431 · Cited by 79 · see citing works

Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis

Bürkner, P., Williams, D. R., Simmons, T. C., & Woolley, J. D. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx053 · Cited by 80 · see citing works

Carbetocin is a Functional Selective Gq Agonist That Does Not Promote Oxytocin Receptor Recycling After Inducing β‐Arrestin‐Independent Internalisation

Passoni, I. P., Leonzino, M., Gigliucci, V., Chini, B., & Busnelli, M. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12363 · Cited by 76 · see citing works

Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment

Goh, K. K., Chen, C.-H., & Lane, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042146 · Cited by 78 · see citing works

Oxytocin reversed MK-801-induced social interaction and aggression deficits in zebrafish

Zimmermann, F. F., Gaspary, K. V., Siebel, A. M., & Bonan, C. D. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.059 · Cited by 75 · see citing works

Personalized medicine in psychiatry

Wium‐Andersen, I. K., Vinberg, M., Kessing, L. V., & McIntyre, R. S. (2016) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2016.1216163 · Cited by 91 · see citing works

Exogenous effects of oxytocin in five psychiatric disorders: a systematic review, meta-analyses and a personalized approach through the lens of the social salience hypothesis

Peled‐Avron, L., Abu-Akel, A. M., & Shamay‐Tsoory, S. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.023 · Cited by 73 · see citing works

Lifespan oxytocin signaling: Maturation, flexibility, and stability in newborn, adolescent, and aged brain

Sannino, S., Chini, B., & Grinevich, V. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22450 · Cited by 70 · see citing works

Oxytocin and Serotonin Brain Mechanisms in the Nonhuman Primate

Lefèvre, A., Richard, N., Jazayeri, M., Beuriat, P.-A., Fieux, S., Zimmer, L., Duhamel, J., & Angela Sirigu, B. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0659-17.2017 · Cited by 71 · see citing works

Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review

Horta, M., Kaylor, K., Feifel, D., & Ebner, N. C. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.012 · Cited by 62 · see citing works

Oxytocin attenuates phencyclidine hyperactivity and increases social interaction and nucleus accumben dopamine release in rats

Kohli, S., King, M. V., Williams, S. A., Edwards, A., Ballard, T. M., Steward, L. J., Alberati, D., & Fone, K. C. F. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0171-0 · Cited by 60 · see citing works

DNA Methylation and Schizophrenia: Current Literature and Future Perspective

Magwai, T., Shangase, K. B., Oginga, F. O., Chiliza, B., Mpofana, T., & Xulu, K. R. (2021) · Cells · doi:10.3390/cells10112890 · Cited by 62 · see citing works

Effects of intranasal oxytocin on symptoms of schizophrenia: A multivariate Bayesian meta-analysis

Williams, D. R., & Bürkner, P. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.10.013 · Cited by 58 · see citing works

Oxytocin differentially modulates specific dorsal and ventral striatal functional connections with frontal and cerebellar regions

Zhao, Z., Ma, X., Geng, Y., Zhao, W., Zhou, F., Wang, J., Markett, S. A., Biswal, B. B., Ma, Y., Kendrick, K. M., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.09.067 · Cited by 55 · see citing works

A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia

Jarskog, L. F., Pedersen, C. A., Johnson, J. L., Hamer, R. M., Rau, S. W., Elliott, T., & Penn, D. L. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.008 · Cited by 55 · see citing works

Intranasal oxytocin administration promotes emotional contagion and reduces aggression in a mouse model of callousness

Zoratto, F., Sbriccoli, M., Martinelli, A., Glennon, J. C., Macrı̀, S., & Giovanni Laviola, A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.010 · Cited by 51 · see citing works

Naringenin: its chemistry and roles in neuroprotection

Atoki, A. V., Aja, P. M., Shinkafi, T. S., Ondari, E. N., & Awuchi, C. G. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2243089 · Cited by 46 · see citing works

Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats

Kozela, E., Krawczyk, M., Kos, T., Juknat, A., Vogel, Z., & Popik, P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01831-2 · Cited by 44 · see citing works

Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt/GSK-3β and Wnt/β-catenin signaling pathways

George, M. Y., Menze, E. T., Esmat, A., Tadros, M. G., & El‐Demerdash, E. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117535 · Cited by 43 · see citing works

Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates

Galbusera, A., Felice, A. D., Girardi, S., Bassetto, G., Maschietto, M., Nishimori, K., Chini, B., Papaleo, F., Vassanelli, S., & Gozzi, A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.283 · Cited by 38 · see citing works

Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies

Potasiewicz, A., Hołuj, M., Litwa, E., Gzieło, K., Socha, L., Popik, P., & Nikiforuk, A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108040 · Cited by 39 · see citing works

Understanding the Oxytocin System and Its Relevance to Psychiatry

Shamay‐Tsoory, S., & Young, L. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.014 · Cited by 39 · see citing works

Reduced DNA Methylation of the Oxytocin Receptor Gene Is Associated With Anhedonia-Asociality in Women With Recent-Onset Schizophrenia and Ultra-high Risk for Psychosis

Bang, M., Kang, J. I., Kim, S. J., Park, J. Y., Kim, K. R., Lee, S. Y., Park, K., Lee, E. M., Lee, S., & An, S. K. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz016 · Cited by 39 · see citing works

Role of neurotransmitters in schizophrenia: a comprehensive study

Bansal, V., & Chatterjee, I. (2021) · Kuwait Journal of Science · doi:10.48129/kjs.v48i2.9264 · Cited by 37 · see citing works

Trauma, Mothering, and Intergenerational Transmission: A Synthesis of Behavioral and Oxytocin Research

Kim, S., & Strathearn, L. (2017) · The Psychoanalytic Study of the Child · doi:10.1080/00797308.2016.1277897 · Cited by 35 · see citing works

Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls

Woolley, J. D., Chuang, B., Fussell, C., Scherer, S. J., Biagianti, B., Fulford, D., Mathalon, D. H., & Vinogradov, S. (2017) · Psychological Medicine · doi:10.1017/s0033291716003433 · Cited by 34 · see citing works

Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients

Liu, Y., Tao, H., Yang, X., Huang, K., Zhang, X., & Li, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00217 · Cited by 32 · see citing works

Oxytocin to modulate emotional processing in schizophrenia: A randomized, double-blind, cross-over clinical trial

Brambilla, M., Cotelli, M., Manenti, R., Dagani, J., Sisti, D., Rocchi, M., Balestrieri, M., Pini, S., Raimondi, S., Saviotti, F. M., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.08.001 · Cited by 31 · see citing works

Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial

Halverson, T. F., Jarskog, L. F., Pedersen, C. A., & Penn, D. L. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.09.013 · Cited by 30 · see citing works

Design of Oxytocin Analogs

Wiśniewski, K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9504-2_11 · Cited by 28 · see citing works

Role of Oxytocin in Different Neuropsychiatric, Neurodegenerative, and Neurodevelopmental Disorders

Ghazy, A. A., Soliman, O., Elbahnasi, A. I., Alawy, A. Y., Mansour, A. M., & Gowayed, M. A. (2022) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2022_72 · Cited by 27 · see citing works

Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis

Davies, C., Paloyelis, Y., Rutigliano, G., Cappucciati, M., Micheli, A. D., Ramella‐Cravaro, V., Provenzani, U., Antoniades, M., Modinos, G., Oliver, D., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0311-6 · Cited by 28 · see citing works

Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism

Moy, S. S., Teng, B. L., Nikolova, V. D., Riddick, N. V., Simpson, C. D., Deusen, A. L. V., Janzen, W. P., Sassano, M. F., Pedersen, C. A., & Jarstfer, M. B. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.10.036 · Cited by 26 · see citing works

Social motivation in schizophrenia: The impact of oxytocin on vigor in the context of social and nonsocial reinforcement.

Fulford, D., Treadway, M. T., & Woolley, J. D. (2018) · Journal of Abnormal Psychology · doi:10.1037/abn0000320 · Cited by 25 · see citing works

Oxytocin and Human Evolution

Carter, C. S. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_18 · Cited by 25 · see citing works

Peripheral oxytocin is inversely correlated with cognitive, but not emotional empathy in schizophrenia

Montag, C., Schöner, J., Speck, L. G., Just, S. A., Stuke, F., Rentzsch, J., Gallinat, J., & Majić, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231257 · Cited by 21 · see citing works

Oxytocin levels in individuals with schizophrenia are high in cerebrospinal fluid but low in serum: A systematic review and meta-analysis

Hernández‐Díaz, Y., González‐Castro, T. B., Tovilla‐Zárate, C. A., López‐Narváez, M. L., Mendoza, A. D. G., Castillo-Ávila, R. G., Ramos-Méndez, M. Á., & Juárez‐Rojop, I. E. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00836-y · Cited by 21 · see citing works

The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance

Hidalgo‐Figueroa, M., Salazar, A., Romero-López-Alberca, C., MacDowell, K. S., García‐Bueno, B., Bioque, M., Bernardo, M., Parellada, M., González-Pinto, A. M., García‐Portilla, M. P., et al. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac023 · Cited by 20 · see citing works

Esquizofrenia: O Que o Médico Não Psiquiatra Precisa de Saber

Queirós, T. P., Coelho, F., Linhares, L., & Telles‐Correia, D. (2019) · Acta Médica Portuguesa · doi:10.20344/amp.10768 · Cited by 20 · see citing works

Insulin-regulated aminopeptidase immunoreactivity is abundantly present in human hypothalamus and posterior pituitary gland, with reduced expression in paraventricular and suprachiasmatic neurons in chronic schizophrenia

Bernstein, H., Müller, S., Dobrowolny, H., Wolke, C., Lendeckel, U., Bukowska, A., Keilhoff, G., Becker, A., Trübner, K., Steiner, J. H., et al. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0757-7 · Cited by 19 · see citing works

Intranasal oxytocin enhances EEG mu rhythm desynchronization during execution and observation of social action: An exploratory study

Festante, F., Ferrari, P. F., Thorpe, S., Buchanan, R. W., & Fox, N. A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104467 · Cited by 18 · see citing works

Oxytocin in dorsal hippocampus facilitates auditory fear memory extinction in rats

Bazaz, A., Ghanbari, A., Vafaei, A. A., Khaleghian, A., & Rashidy‐Pour, A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108844 · Cited by 18 · see citing works

Unaltered Oxytocin and Vasopressin Plasma Levels in Patients with Schizophrenia After 4 Months of Daily Treatment with Intranasal Oxytocin

Busnelli, M., Dagani, J., de Girolamo, G., Balestrieri, M., Pini, S., Saviotti, F. M., Scocco, P., Sisti, D., Rocchi, M., & Chini, B. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12359 · Cited by 18 · see citing works

Phosphorylation-dependent positive feedback on the oxytocin receptor through the kinase PKD1 contributes to long-term social memory

Wang, F., Yin, X.-S., Lu, J., Cen, C., & Wang, Y. (2022) · Science Signaling · doi:10.1126/scisignal.abd0033 · Cited by 15 · see citing works

Relationship between the domains of theory of mind, social dysfunction, and oxytocin in schizophrenia

Goh, K. K., & Lu, M. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.09.013 · Cited by 16 · see citing works

Linking childhood trauma to the psychopathology of schizophrenia: the role of oxytocin

Chen, Y.-J., Lu, M., Chiu, Y.-H., Chen, C., Santos, V. H. J., & Goh, K. K. (2024) · Schizophrenia · doi:10.1038/s41537-024-00433-9 · Cited by 16 · see citing works

Peptide synthesis: a review of classical and emerging methods

Cai, Z. Y., Liu, L., Zou, C. H., Jiang, X. P., Wang, G., He, X. J., Zhuang, W., Yang, C., Yao, Y., Sun, X., et al. (2025) · Biofabrication · doi:10.1088/1758-5090/ae1bdc · Cited by 15 · see citing works

Endogenous oxytocin response to film scenes of attachment and loss is pronounced in schizophrenia

Speck, L. G., Schöner, J., Bermpohl, F., Heinz, A., Gallinat, J., Majić, T., & Montag, C. (2018) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsy110 · Cited by 15 · see citing works

Oxytocin Receptor (OXTR) Methylation and Cognition in Psychotic Disorders

Grove, T. B., Burghardt, K. J., Kraal, A. Z., Dougherty, R. J., Taylor, S. F., & Ellingrod, V. L. (2016) · Complex Psychiatry · doi:10.1159/000448173 · Cited by 15 · see citing works

Intranasal oxytocin modulates higher order social cognition in body dysmorphic disorder

Fang, A., Lawson, E. A., & Wilhelm, S. (2019) · Depression and Anxiety · doi:10.1002/da.22876 · Cited by 14 · see citing works

The importance of pro-social processing, and ameliorating dysfunction in schizophrenia. An FMRI study of oxytocin

Wigton, R. L., Tracy, D. K., Verneuil, T., Johns, M., White, T. P., Michalopoulou, P. G., Averbeck, B. B., & Shergill, S. S. (2021) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2021.100221 · Cited by 14 · see citing works

Binding Characteristics of Two Oxytocin Variants and Vasopressin at Oxytocin Receptors from Four Primate Species with Different Social Behavior Patterns

Taylor, J. H., Schulte, N. A., French, J. A., & Toews, M. L. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.250852 · Cited by 14 · see citing works

Contribution of oxytocin receptor polymorphisms to amygdala activation in schizophrenia spectrum disorders

Haram, M., Bettella, F., Brandt, C. L., Quintana, D. S., Nerhus, M., Bjella, T., Djurovic, S., Westlye, L. T., Andreassen, O. A., Melle, I., et al. (2016) · BJPsych Open · doi:10.1192/bjpo.bp.116.003376 · Cited by 13 · see citing works

The implications of hypothalamic abnormalities for schizophrenia

Bernstein, H., Keilhoff, G., & Steiner, J. H. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00008-3 · Cited by 13 · see citing works

The Time Course of Dorsal and Rostral-Ventral Anterior Cingulate Cortex Activity in the Emotional Stroop Experiment Reveals Valence and Arousal Aberrant Modulation in Patients with Schizophrenia

Feroz, F. S., Leicht, G., Rauh, J., & Mulert, C. (2018) · Brain Topography · doi:10.1007/s10548-018-0677-0 · Cited by 13 · see citing works

Acute oxytocin effects in inferring others’ beliefs and social emotions in people at clinical high risk for psychosis

Schmidt, A., Davies, C., Paloyelis, Y., Meyer, N., Micheli, A. D., Ramella‐Cravaro, V., Provenzani, U., Aoki, Y. Y., Rutigliano, G., Cappucciati, M., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00885-4 · Cited by 13 · see citing works

Symptomatic thinking: the current state of Phase III and IV clinical trials for cognition in schizophrenia

Talpos, J. C. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.04.014 · Cited by 11 · see citing works

Enhancement of Oxytocin in the Medial Prefrontal Cortex Reverses Behavioral Deficits Induced by Repeated Ketamine Administration in Mice

Zhu, W., Ding, Z., Zhang, Z., Wu, X. A., Liu, X., Zhang, Y., Li, S., Zhou, L., Tian, G., & Qin, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.723064 · Cited by 10 · see citing works

Approaches to Improve the Quantitation of Oxytocin in Human Serum by Mass Spectrometry

Hering, A., Jieu, B., Jones, A., & Muttenthaler, M. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.889154 · Cited by 9 · see citing works

Preliminary evidence that oxytocin does not improve mentalizing in women with schizophrenia

Bradley, E., Tai, M. L., Hankin, M., & Woolley, J. D. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104915 · Cited by 9 · see citing works

Impact of long‐term institutionalization on experiential pleasure and motivation in patients with schizophrenia

Chu, M., Hu, H., Ni, H., Lu, W., Lui, S. S. Y., Yi, Z.-H., Cheung, E. F. C., & Chan, R. C. K. (2019) · PsyCh Journal · doi:10.1002/pchj.300 · Cited by 9 · see citing works

Antipsychotic lurasidone: Behavioural and pharmacokinetic data in C57BL/6 mice

Percelay, S., Since, M., Lagadu, S., Fréret, T., Bouët, V., & Boulouard, M. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172933 · Cited by 8 · see citing works

Rodent models of genetic and chromosomal variations in psychiatric disorders

Nomura, J., Kannan, G., & Takumi, T. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12524 · Cited by 8 · see citing works

Toward effective oxytocin interventions in autism: Overcoming challenges and harnessing opportunities

Ricchiuti, G., Tuerlinckx, E., Taillieu, A., Prinsen, J., Steyaert, J. G., Boets, B., & Alaerts, K. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811241309621 · Cited by 7 · see citing works

Effects of ulotaront on brain circuits of reward, working memory, and emotion processing in healthy volunteers with high or low schizotypy

Perini, F., Nazimek, J. M., McKie, S., Capitão, L. P., Scaife, J. C., Pal, D., Browning, M. D., Dawson, G. R., Nishikawa, H., Campbell, U. C., et al. (2023) · Schizophrenia · doi:10.1038/s41537-023-00385-6 · Cited by 8 · see citing works

Oxytocin enhances the triangular association among behavior, resting‐state, and task‐state functional connectivity

Zhang, H., Chen, K., Bao, J., & Wu, H. (2023) · Human Brain Mapping · doi:10.1002/hbm.26498 · Cited by 7 · see citing works

The Effects of Augmenting Clozapine with Oxytocin in Schizophrenia: An Initial Case Series

Marotta, R. F., Buono, F. D., Garakani, A., Collins, E. D., Cerrito, B., & Rowe, D. (2020) · Annals of Clinical Psychiatry · doi:10.1177/104012372003200211 · Cited by 7 · see citing works

From Parental Behavior to Sexual Function: Recent Advances in Oxytocin Research

Dale, J. K., Harberson, M. T., & Hill, J. W. (2024) · Current Sexual Health Reports · doi:10.1007/s11930-024-00386-1 · Cited by 7 · see citing works

Pro-social and pro-cognitive effects of LIT-001, a novel oxytocin receptor agonist in a neurodevelopmental model of schizophrenia

Piotrowska, D., Potasiewicz, A., Popik, P., & Nikiforuk, A. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.09.005 · Cited by 7 · see citing works

Lipid-based nanostructures in targeted management of neurological disorders: A comprehensive review

Guleria, M., Kamble, A., Upadhyay, M., Sethi, P., Patel, M. B., Malhan, A., Rastogi, S., Datta, D., Singh, S. A., & Prajapati, B. G. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126530 · Cited by 6 · see citing works

Opinion: Real-Time fMRI Neurofeedback and the Application of the Neuropeptide Oxytocin as Promising New Treatment Approaches in Internet Addiction?

Becker, B., & Montag, C. (2017) · Studies in neuroscience, psychology and behavioral economics · doi:10.1007/978-3-319-46276-9_18 · Cited by 5 · see citing works

The oxytocin system mediates behavioral and neurobiological alterations associated with early adversity

Municchi, D., Mancini, C., Nutarelli, S., Tiberi, M., D’Addario, S. L., Chila, G., Passeri, A., Massa, G., Segni, M. D., Babicola, L., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03437-8 · Cited by 4 · see citing works

Investigation and Analysis of Emotional State and Oxytocin Level in Patients with Postpartum Depression

Yu, X., Zhang, W., & Gao, Y. (2024) · Actas Españolas de Psiquiatría · doi:10.62641/aep.v52i3.1627 · Cited by 4 · see citing works

Add-on Oxytocin in the Treatment of Postpartum Acute Schizophrenia: A Case Report

Medved, S., Janović, M. B., Štimac, Z., & Mihaljević-Peleš, A. (2021) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000557 · Cited by 4 · see citing works

Update on Oxytocin, Phosphodiesterase, Neurokinin, Glycine as a Therapeutic Approach in the Treatment of Schizophrenia

Doshi, G., Bhatia, N. Y., Ved, H. S., Pandya, A., Kulkarni, D., Naik, J., Bandiwadekar, T., Godad, A. P., & Kale, P. P. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220817161035 · Cited by 3 · see citing works

Contrasting Effects of Oxytocin on MK801-Induced Social and Non-Social Behavior Impairment and Hyperactivity in a Genetic Rat Model of Schizophrenia-Linked Features

Sampedro-Viana, D., Cañete, T., Ancil-Gascón, P., Cisci, S., Tobeña, A., & Fernández‐Teruel, A. (2024) · Brain Sciences · doi:10.3390/brainsci14090920 · Cited by 3 · see citing works

Epigenetic Control in Schizophrenia

D’Addario, C., & Bartolomeo, M. D. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-75980-2_5 · Cited by 3 · see citing works

Serum Oxytocin Concentration in Patients Receiving Electroconvulsive Therapy

Barhale, C., Raju, M. S. V. K., Pawar, A. V., Kadam, K., Sousa, A. D., & Andrade, C. (2017) · Journal of Ect · doi:10.1097/yct.0000000000000388 · Cited by 3 · see citing works

Intranasal Oxytocin in Pediatric Populations: Exploring the Potential for Reducing Irritability and Modulating Neural Responses: A Mini Review

Sorenson, K., Kendall, E., Grell, H., Kang, M., Shaffer, C. L., & Hwang, S. (2023) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20230008 · Cited by 3 · see citing works

Receptor for advanced glycation end-products and child neglect in mice: A possible link to postpartum depression

Higashida, H., Gerasimenko, M., & Yamamoto, Y. (2022) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2022.100146 · Cited by 3 · see citing works

Oxytocin and postpartum depression - a possible treatment for depressed mothers

Leziak, M., Niedobylski, S., Żak, K., Piwoński, M., Krasowska, D., & Skórzyńska-Dziduszko, K. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.07.016 · Cited by 2 · see citing works

A new two-hit animal model for schizophrenia research: Consequences on social behavior

Hakenova, K., Mikulecká, A., Holubová, K., Chvojková, M., Šlamberová, R., Jur̀čovičová, J., Čechová, B., Poništ, S., Horáček, J., & Valeš, K. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.05.012 · Cited by 2 · see citing works

Trust and Oxytocin

Yan, Z., & Kirsch, P. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108770880.018 · Cited by 2 · see citing works

External stress, formaldehyde, and schizophrenia: a new mouse model for mental illness research

Cheng, J., Sun, Z., Zhang, H., Zhao, D., Wang, P., Chen, H., Lyv, W., Deng, Q., Fu, Y., Lyv, X., et al. (2025) · Schizophrenia · doi:10.1038/s41537-025-00603-3 · Cited by 1 · see citing works

Integrated Bioinformatics Analyses of Peripheral Blood Transcriptomes Reveals Shared Molecular Features Underlying the Comorbidity of Schizophrenia and Metabolic Syndrome

Zhang, Y., Hao, M., & Hu, Y. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02431-7 · Cited by 1 · see citing works

The role of oxytocin in the pathogenesis and treatment of schizophrenia

Jusiak, K., Brudkowska, Ż., Gołębiowska, M., Morylowska-Topolska, J., Gołębiowska, B., Próchnicki, M., Próchnicka, A., & Karakuła‐Juchnowicz, H. (2017) · Current Problems of Psychiatry · doi:10.1515/cpp-2017-0023 · Cited by 1 · see citing works

Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment – need for more short- and long-term studies

Gul, O., Gul, S., & Aziz, A. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s183645 · Cited by 1 · see citing works

Potential of Oxytocin in the Treatment of Schizophrenia

Shilling, P. D., & Feifel, D. (2016) · CNS Drugs · doi:10.1007/s40263-016-0315-x · Cited by 82 · see citing works

A Role for Oxytocin in the Etiology and Treatment of Schizophrenia

Rich, M. E., & Caldwell, H. K. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00090 · Cited by 55 · see citing works

Oxytocin in schizophrenia: a review of evidence for its therapeutic effects

MacDonald, K. S., & Feifel, D. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00634.x · Cited by 111 · see citing works

Oxytocin and Schizophrenia Spectrum Disorders

Ettinger, U., Hurlemann, R., & Chan, R. C. K. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_27 · Cited by 16 · see citing works

Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward

Bradley, E., & Woolley, J. D. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.007 · Cited by 88 · see citing works